Analysis | Metabolite Name | Measured Value | Units | Sample | TREATMENT |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 0.7017 | Peak area | Plasma | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 0.8022 | Peak area | Plasma | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 0.8192 | Peak area | Plasma | Saline |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 0.8349 | Peak area | Plasma | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 0.8599 | Peak area | Plasma | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 0.9036 | Peak area | Plasma | Saline |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 0.9439 | Peak area | Plasma | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 0.956 | Peak area | Plasma | Saline |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 0.9632 | Peak area | Plasma | Saline |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 0.9705 | Peak area | Plasma | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 0.978 | Peak area | Plasma | Saline |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 0.9873 | Peak area | Plasma | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.0127 | Peak area | Plasma | Saline |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.0346 | Peak area | Plasma | Saline |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.0576 | Peak area | Plasma | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.0758 | Peak area | Plasma | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.0888 | Peak area | Plasma | Saline |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.0983 | Peak area | Plasma | Saline |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.1106 | Peak area | Plasma | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.1481 | Peak area | Plasma | Saline |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.2086 | Peak area | Plasma | Saline |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.218 | Peak area | Plasma | Saline |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.3605 | Peak area | Plasma | Angiotensin II |
Reversed phase NEGATIVE ION MODE | 1,2-dipalmitoyl-GPC (16:0/16:0) | 1.6085 | Peak area | Plasma | Angiotensin II |